Steady-State Serum IgG Trough Levels Are Adequate for Pharmacokinetic Assessment in Patients with Immunodeficiencies Receiving Subcutaneous Immune Globulin

Patients with primary immunodeficiency diseases often require lifelong immunoglobulin (IG) therapy. Most clinical trials investigating IG therapies characterize serum immunoglobulin G (IgG) pharmacokinetic (PK) profiles by serially assessing serum IgG levels. This retrospective analysis evaluated wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhaoyang, McCoy, Barbara, Engl, Werner, Yel, Leman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310849/
https://www.ncbi.nlm.nih.gov/pubmed/34036490
http://dx.doi.org/10.1007/s10875-021-00990-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310849/
https://www.ncbi.nlm.nih.gov/pubmed/34036490
http://dx.doi.org/10.1007/s10875-021-00990-z

Ejemplares similares